908 Devices Raises Revenue Outlook on Strong Q2 Growth
Event summary
- 908 Devices reported Q2 2026 revenue of $16.1 million, up 23% YoY.
- Adjusted EBITDA loss narrowed by more than half to $1.9 million.
- Raised low end of 2026 revenue guidance to $68.0M-$70.0M (from $67.0M-$70.0M).
- Shipped over 35 VipIR devices in Q2, including 18 to a South Asia law enforcement agency.
- Secured a $6 million ProtectIR order from an Asia-Pacific corrections agency post-quarter.
The big picture
908 Devices is capitalizing on the modernization of law enforcement and safety agencies, with a focus on handheld chemical analysis tools. The company's ability to secure large orders from international customers highlights its growing relevance in global security markets. With a strong cash position and improving margins, 908 Devices appears well-positioned to execute its growth strategy.
What we're watching
- Product Adoption Pace
- How quickly NIRLab gains traction in the U.S. market after its recent acquisition.
- Government Contracts
- Whether the momentum with U.S. state and local customers can be sustained.
- Operational Efficiency
- The pace at which 908 Devices can further narrow its Adjusted EBITDA loss.
